Bharat Biotech on Friday said it has dispatched COVID vaccine Covaxin to various states like Gujarat, Assam, Tamil Nadu, Karnataka and Odisha.
The Hyderabad-based vaccine major, which has come under fire from the Delhi government over supply-related issues, said it has also dispatched Covaxin lots to Kerala and Uttarakhand.
"Covaxin goes to Gandhinagar, Guwahati, Chennai, Hyderabad, Bengaluru & Bhuvneshwar. thank all our employees @ BHarat bio who worked thru the holy month of Ramzan..." Bharat Biotech Co-Founder and Joint Managing Director Suchitra Ella said in a tweet.
Earlier in a late night tweet on Thursday, she tweeted informing supply of the much in demand vaccine to Kerala and Uttarakhand.
"Covaxin sent to Kerala & Uttarakhand. Thanq for the concern, many offered to help. Our work is highly stringent, realtime & technical,no work from home! All Our employees will be taken care of, won't deter us from our mission! Let's be thankful,helpful & hopeful always," she tweeted.
Ella however did not provide details on the quantum of supplies.
On May 12, Delhi Deputy Chief Minister Manish Sisodia said that Bharat Biotech has informed the state government that it cannot provide 'additional' Covaxin doses to the national capital.
Responding to the criticism, Ella in a tweet said that It was quite disheartening to listen to some states complaining about the company's intentions regarding supply of Covaxin.
She said that the company had already dispatched Covaxin lots to 18 states on May 10.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)